|
|
|
|
REFERENCES
Acheson ED: Hodgkin's disease in woodworkers. Lancet ii:988-989, 1967. Axtel LM, Myers MH, Thomas LH, et al.: Prognostic indicators in Hodgkin's disease. Cancer 29:1481-1488, 1972. Boring CC, Squires TS and Tong T: Cancer Statistics 1994.
CA Cancer J Clin 44:7-26, 1994. Chakravati A, Hallorau SL, Bale SJ et al.: Etiologic heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance. Genet Epedemiol 3(6):407-415, 1986. Clark DA, Alexander FE, McKinney PA, et al.: The epidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma. Int J Cancer 45:829-833, 1990. Cole P, MacMahon B and Aisenberg A: Mortality from Hodgkin's disease in the U.S.: Evidence for the multiple aetiology hypothesis. Lancet 2(583):1371-1376, 1968. Correa P and O'Conor GT: Epidemiologic patterns of Hodgkin's disease. Int J Cancer 8:192-201, 1971. Forbes JF and Morris PJ: Leucocyte antigens in Hodgkin's
disease. Lancet 2(678):849-851, 1970. Fraumeni JF Jr and Li FP: Hodgkin's disease in childhood: An epidemiologic study. J Natl Cancer Inst 42:681-691, 1969. Grufferman S: Hodgkin's Disease. In Cancer Epidemiology and Prevention. (Schottenfeld D, Fraumeni, JF Jr, eds.). Philadelphia: W. B. Saunders, 739-753, 1982. Gutensohn NM: Social class and age at diagnosis of Hodgkin's disease: New epidemiologic evidence for
the "two-disease hypothesis." Cancer Treat Rep
66:689-695, 1982. Hardell L, Eriksson M, Lenner P, et al.: Malignant lymphoma and exposure to chemicals, especially organic
solvents, chlorophenols and phenoxy acids: a case-control study. Br J Cancer 43:169-176, 1981. Hoar SK, Blair A, Holmes FF, et al.: Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma.
JAMA 256:1141-1147, 1986. [Published erratum
appears in JAMA 1986 Dec.] Jarrett RF, Gallagher A, Jones DB, et al.: Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age. J Clin Path 44:844-848, 1991. Johansson B, Klein G, Henle Wet, et al.: Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukaemia. I. Hodgkin's disease. Int J Cancer 6:450-462, 1970. Lantorp K, Wahren B and Hanngren A: Infectious
mononucleosis and depression of cellular immunity.
BMJ 4:668, 1972. Levine PH, Ablashi DV, Berard CW, et al.: Elevated antibody titers to herpes-type virus in Hodgkin's disease. Proc Am Assoc Cancer Res 11:49, 1970. Levine PH, Ablashi DV, Berard CW, et al.: Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer 27:416-421, 1971. Levine PH, Ebbesen P, Ablashi DV, et al.: Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease. Int J Cancer 51:53-57, 1992. Levine PH, Lin A and Tucker MA: What can we learn about the etiology of Hodgkin's disease from family studies? In The Aetiology of Hodgkin's Disease. (Jarrett R, ed.). London: Plenum Press (in press) (a). Levine PH, Manak M and Jagodzinski L: Hodgkin's disease and human herpesvirus-6: A model for studies of new etiologic agents. In The Aetiology of Hodgkin's Disease. (Jarrett R, ed.). London: Plenum Press, (in press) (b). MacMahon B: Epidemiologic evidence on the nature of Hodgkin's disease. Cancer 10:1045-1054, 1957. Mangi RJ, Niederman JC and Helleher JE Jr: Depression of cell-mediated immunity during acute infectious mononucleosis. N Engl J Med 291:1149-1153, 1974. Mueller N: An epidemiologist's view of the new molecular biology findings in Hodgkin's disease. Ann Oneal (suppl) 2:23-28, 1991. Mueller N, Evans A, Harris NL, et al.: Hodgkin's disease and Epstein-Barr virus: Altered antibody pattern before diagnosis. N Engl J Med 320:689-695, 1989. Mueller N, Swanson GM, Hsieh CC, et al.: Tonsillectomy and Hodgkin's disease: Results from companion population-based studies. J Natl Cancer Inst 78:1-5, 1987. National Conference on Clustering of Health Events:
Am J Epidemiol (suppl) 132:S1-S202, 1990. Newell GR: Etiology of multiple sclerosis and Hodgkin's
disease. Am J Epidemiol 2:119-122, 1970. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al.: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320-322, 1991. Parkin DM, Muir CS, Whelan S, et al.: Cancer Incidence in Five Continents, vol VI. IARC Scientific Publication No. 120. World Health Organization, International Agency for Research on Cancer, Lyon, 1992. Ries LAG, Miller BA, Hankey BF, et al.: SEER Cancer Statistics Review, 1973-1991: Tables and Graphs,
National Cancer Institute. NIH Publ. No. 94-2789, Bethesda, MD, 1994. Spector BD, Filipovich AH, Perry GS, III, et al.: Epidemiology of cancer in ataxia-telangiectasia.
pp.103-137. In Ataxia-telangiectasia--A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency. (Bridges BA, Harnden DG, eds.). New York: John Wiley and Sons Ltd, 1982. Torelli G, Marasca R, Luppi M, et al.: Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase
chain reaction. Blood 77:2251-2258, 1991. Vianna NJ, Greenwald P and Davies JNP: Extended epidemic of Hodgkin's disease in high school students. Lancet 1(711):1209-1211, 1971. Weiss LM, Movahed LA, Warnke RA, et al.: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502-506, 1989. Wright DH: Pathology of Hodgkin's disease: Anything new? pp. 2-13. In New aspects in the diagnosis and treatment of Hodgkin's disease. Recent Results in Cancer Research. Berlin, (Diehl V, Pfreundschuh M, Loeffler M, eds.). New York: Springer-Verlag, 1989. |
